Advanced search
Publication Cover
Renal Failure Volume 32, 2010 - Issue 5
Submit an article Journal homepage
1,062
Views
14
CrossRef citations to date
0
Altmetric
Clinical Studies

Comparison of immunosuppressive therapeutic regimens in patients with nephrotic syndrome due to idiopathic membranous nephropathy

George Kosmadakis Department of Nephrology “Gregorios Vosnides”, Laiko General Hospital, Athens, GreeceCorrespondence[email protected]
,
Vasileios Filiopoulos Department of Nephrology “Gregorios Vosnides”, Laiko General Hospital, Athens, Greece
,
Despoina Smirloglou Department of Nephrology “Gregorios Vosnides”, Laiko General Hospital, Athens, Greece
,
Panayotis Skarlas Department of Nephrology “Gregorios Vosnides”, Laiko General Hospital, Athens, Greece
,
Christodoulos Georgoulias Department of Nephrology “Gregorios Vosnides”, Laiko General Hospital, Athens, Greece
&
Spiridon Michail Department of Nephrology “Gregorios Vosnides”, Laiko General Hospital, Athens, Greece
Pages 566-571 | Received 22 Dec 2009, Accepted 07 Feb 2010, Published online: 20 May 2010

REFERENCES

  • Mason PD, Pusey CD. Glomerulonephritis: Diagnosis and treatment. BMJ. 1994;309(6968):1557–1563.
  • Honkanen E, Törnroth T, Grönhagen-Riska C. Natural history, clinical course and morphological evolution of membranous nephropathy. Nephrol Dial Transplant. 1992;(Suppl. 1):35–41.
  • Ponticelli C, Passerini P. Membranous nephropathy. In: Ponticelli C, Glassock RJ, eds. Treatment of Primary Glomerulonephritis. Oxford: Oxford University Press; 1997:146–185.
  • Passerini P, Pasquali S, Cesana B, Zucchelli P, Ponticelli C. Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria. Nephrol Dial Transplant. 1989;4:525–529.
  • Quaglia M, Stratta P. Idiopathic membranous nephropathy: Management strategies. Drugs. 2009;69(10):1303–1317.
  • Hogan SL, Muller KE, Jennette JC, Falk RJ. A review of therapeutic studies of idiopathic membranous glomerulopathy. Am J Kidney Dis. 1995;25:862–875.
  • Imperiale TF, Goldfarb S, Berns JS. Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A meta-analysis of the controlled trials. J Am Soc Nephrol. 1995;5:1553–1558.
  • Fujimoto S, Hara S, Sato Y, Yamada K, Hisanaga S, Eto T. Nephrotic syndrome caused by membranous nephropathy: Response to a short course of cyclophosphamide alternating with prednisolone. Intern Med. 2004;43(1):30–34.
  • Goumenos DS, Kalliakmani P, Tsakas S, Sotsiou F, Vlachojannis JG. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy. Clin Nephrol. 2004;61(1):17–24.
  • Branten AJ, Reichert LJ, Koene RA, Wetzels JF. Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency. QJM. 1998;91(5):359–366.
  • Schieppati A, Perna A, Zamora J, Giuliano GA, Braun N, Remuzzi G. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome. Cochrane Database Syst Rev. 2004;18(4):CD004293.
  • Praga M, Hernández E, Montoyo C, Andrés A, Ruilope LM, Rodicio JL. Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis. 1992;20(3):240–248.
  • Tylicki L, Rutkowski P, Renke M, Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: An open-label crossover randomized controlled trial. Am J Kidney Dis. 2008;52(3):486–493.
  • The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet. 1997;349(9069):1857–1863.
  • Ruggenenti P, Mosconi L, Vendramin G, ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome. Am J Kidney Dis. 2000;35:381–391.
  • Gansevoort RT, Heeg JE, Vriesendorp R, de Zeeuw D, de Jong PE. Antiproteinuric drugs in patients with idiopathic membranous glomerulopathy. Nephrol Dial Transplant. 1992;7(Suppl. 1):91–96.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.